Discontinuation rate of nevirapine-based highly active antiretroviral therapy

AIDS Res Hum Retroviruses. 2012 Jan;28(1):82. doi: 10.1089/AID.2011.0114. Epub 2011 Jun 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active* / adverse effects
  • CD4 Lymphocyte Count
  • Chemical and Drug Induced Liver Injury / epidemiology*
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / epidemiology*
  • Humans
  • Male
  • Nevirapine / administration & dosage*
  • Nevirapine / adverse effects*
  • Risk Factors
  • Withholding Treatment

Substances

  • Nevirapine